by Kevon Browne
St Kitts and Nevis (WINN): As we know St. Kitts-Nevis has procured some 21,600 doses of the Oxford/AstraZeneca vaccine through the US$800,000.00 pay to the COVAX facility, which would inoculate 20 percent of the federation’s population.
The delivery was said to commence during the second half of February through the second quarter of 2021 (April-June), with the decision for emergency use slated for the first week in February (1-7).
According to the World Health Organization’s (WHO) Emergency Use Listing Procedure’s (EUL) status report last updated February 8, the anticipated decision date of the Oxford/AstraZeneca through COVAX is March-April 2021.
See the full report below:
https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_08Feb2021.pdf
Subsequent to the anticipated delivery announcement, Chief Medical Officer, Dr. Hazel Laws mentioned during the February 3 National Emergency Operations Center Press Briefing that St. Kitts-Nevis is actively sourcing vaccines through two other avenues.
During a Cabinet briefing in Grenada on February 10, Minister of Health Nickolas Steele stated that heads of government from OECS and CARICOM member states took a collective decision two weeks ago to procure vaccines through India and some nations of Africa.
Is India and Africa the two other sources that Dr. Laws mentioned?
Steele made those remarks in answering a question concerning the shipment of about 170,000 doses of the Oxford/AstraZeneca vaccine and the announcement by Prime Ministers Mia Mottley and Roosevelt Skerrit, saying they would share the shipments with OECS member states as well as Guyana and Trinidad and Tobago.
